Increasing public support for supervised injection facilities in Ontario, Canada

Addiction

Volumn 109, Issue 6, 2014, Pages 946-953

  Strike, Carol ^a,b   Jairam, Jennifer A ^c   Kolla, Gillian ^a   Millson, Peggy ^a   Shepherd, Susan ^d   Fischer, Benedikt ^b,e   Watson, Tara Marie ^a   Bayoumi, Ahmed M ^c,f,g,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d Toronto Public Health   (Canada)

^e SIMON FRASER UNIVERSITY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Adult; Canada; General population; Public opinion; Supervised injection facilities; Telephone survey

Indexed keywords

EID: 84899944229     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12506     Document Type: Article

References (38)

1. Dolan K., Kimber J., Fry C., McDonald D., Fitzgerald J., Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev 2000; 19: 337-346.
2. Bayoumi A. M., Strike C., Jairam J., Watson T., Enns E., Kolla G. etal. Report of the Toronto and Ottawa Supervised Consumption Assessment Study. Toronto: St Michael's Hospital and the Dalla Lana School of Public Health, University of Toronto; 2012. Available at: http://www.toscastudy.ca/toscastudy.ca/TOSCA_Report.html (accessed 17 May 2013) (Archived at: http://www.webcitation.org/6NekvAVj5 on 25 February 2014).
3. Hedrich D. European Report on Drug Consumption Rooms. Lisbon: European Monitoring; 2004.
4. Kimber J., Dolan K., van Beek I., Hedrich D., Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev 2003; 22: 227-233.
5. Salmon A., Thein R., Kimber J., Kaldor J., Maher L. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy 2007; 18: 46-53.
6. Hedrich D., Kerr T., Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T., Hedrich D., editors. European Monitoring Centre for Drugs and Drug Addiction EMCDDA Scientific Monograph Series no. 10. Harm Reduction: Evidence, Impacts and Challenges. Luxembourg: Publications Office of the European Union; 2010, pp. 305-331.
7. Ritter A., Lancaster K. Measuring research influence on drug policy: a case example of two epidemiological monitoring systems. Int J Drug Policy 2013; 24: 30-37.
8. Wood E., Kerr T., Small W., Li K., Marsh D. C., Julio S. G. etal. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J 2004; 171: 731-734.
9. Kerr T., Tyndall M., Li K., Montaner J. S. G., Wood E. Safer injecting facility use and syringe sharing in IDUs. Lancet 2005; 366: 316-318.
10. Kimber J., Dolan K., Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug Alcohol Rev 2005; 24: 21-24.
11. Marshall B. D., Milloy M., Wood E., Montaner J. S., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011; 377: 1429-1437.
12. Vernick J. S., Burris S., Strathdee S. A. Public opinion about syringe exchange programmes in the USA: an analysis of national surveys. Int J Drug Policy 2003; 14: 431-435.
13. Stöver H. Consumption rooms: a middle ground between health and public order concerns. J Drug Issues 2002; 32: 597-606.
14. MacDonald M., Rutter S., Wodak A., Kaldor J. K2 and Kings Cross: community attitudes to the needle syringe program, discarded needles, and public injection, 1997 and 1988. Sydney: New South Wales Health Department; 1999.
15. Thein H. H., Kimber J., Maher L., MacDonald M., Kaldor J. M. Public opinion towards supervised injecting centres and the Sydney Medically Supervised Injecting Centre. Int J Drug Policy 2005; 16: 275-280.
16. Burstein P. The impact of public opinion on public policy: a review and an agenda. Polit Res Q 2003; 56: 29-40.
17. Hyshka E., Bubela T., Wild T. C. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making. Addiction 2013; 108: 468-476.
18. Firestone-Cruz M. F., Patra J., Fischer B., Rehm J., Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy 2007; 18: 54-61.
19. Ialomiteanu A., Adlaf E. M. CAMH Monitor 2003: Technical Guide. Toronto: Centre for Addiction and Mental Health; 2004.
20. Ialomiteanu A., Adlaf E. M. CAMH Monitor 2009: Technical Guide. Toronto: Centre for Addiction and Mental Health; 2010. Available at: http://www.camh.net/Research/camh_monitor.html (accessed 17 May 2013) (Archived at: http://www.webcitation.org/6NelFbc9l on 25 February 2014).
21. Rao J. N. K., Scott A. J. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat 1984; 12: 46-60.
22. Demnati A., Rao J. N. K. Linearization variance estimators for survey data. Surv Methodol 2004; 30: 17-26.
23. Austin P. C., Tu J. V. Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 2004; 5: 1138-1146.
24. Korn E. L., Graubard B. I. Analysis of Health Surveys. New York: Wiley; 1999.
25. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP; 2009.
26. Strike C., Watson T. M., Kolla G., Penn R., Luce J., Shepherd S. etal. Conditional acceptance and rejection of supervised consumption sites (SCSs)-opinions of community stakeholders in Toronto and Ottawa. Can J Infect Dis Med Microbiol 2011; 22: 108B.
27. Jairam J., Strike C., Kolla G., Millson P., Shepherd S., Watson T. M. etal. Public opinions of supervised consumption sites: perspectives from Ontario residents. Can J Infect Dis Med Microbiol 2011; 22: 105B.
28. Stoltz J. A., Wood E., Small W., Li K., Tyndall M., Montaner J. etal. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf) 2007; 29: 35-39.
29. Petrar S., Kerr T., Tyndall M. W., Zhang R., Montaner J. S., Wood E. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Addict Behav 2007; 32: 1088-1093.
30. Watson T. M., Bayoumi A., Kolla G., Penn R., Fischer B., Luce J. etal. Police perceptions of supervised consumption sites (SCSs): a qualitative study. Subst Use Misuse 2012; 47: 364-374.
31. Ontario Harm Reduction Distribution Program. Environmental Scan 2013. Kingston, Ontario: Kingston Community Health Centres; 2013.
32. Strike C., Watson T. M., Lavigne P., Hopkins S., Shore R., Young D. etal. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Int J Drug Policy 2011; 22: 34-40.
33. Dutra L., Stathopoulou G., Basden S. L., Leyro T. M., Powers M. B., Otto M. W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179-187.
34. Farre M., Mas A., Torrens M., Moreno V., Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 2002; 65: 283-290.
35. Substance Use and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Results from the 2008 National Survey on Drug Use and Health: National Findings. Rockville, MD: SAMHSA; 2009.
36. Wood E., Tyndall M. W., Zhang R., Montaner J. S., Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007; 102: 916-919.
37. Canada (Attorney General) v. PHS Community Services Society. 2011. SCC 44, [2011] 3 S.C.R. 134.
38. Dale D. Ontario rejects Toronto's call for supervised drug injection site. Toronto Star, July 10, 2013. Available at: http://www.thestar.com/news/gta/2013/07/10/ontario_rejects_torontos_call_for_supervised_drug_injection_site.html (accessed 10 July 2013) (Archived at: http://www.webcitation.org/6Nem2ez9G on 25 February 2014).